Department of Medicine, Division of Hematology and Oncology, Thrombosis and Hemostasis Program, UNC McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; K.G. Jensen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.
Department of Medicine, Division of Hematology and Oncology, Thrombosis and Hemostasis Program, UNC McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Thromb Res. 2017 Feb;150:65-72. doi: 10.1016/j.thromres.2016.12.021. Epub 2016 Dec 23.
Increased levels of tissue factor-positive extracellular vesicles (TF+EVs) have been detected in the plasma of patients with various diseases, including cancer and endotoxemia. Levels of TF+EVs in plasma samples can be measured by antigen and activity assays. The aim of the present study was to visualize TF+EVs by laser scanning confocal microscopy (LSCM).
EVs were isolated from the supernatant of two cultured human pancreatic cancer cell lines (Panc-1 and BxPc-3), from untreated or lipopolysaccharide (LPS) treated whole blood, and from plasma of pancreatic cancer patients. EV-TF activity was determined using an in-house assay. The EVs were labeled with 5(6)-carboxyfluorescein diacetate N-succinimidyl ester, which is converted to the impermeant green fluorescent molecule carboxyfluorescein inside the EVs. EVs were either captured using annexin V and detected using a fluorescent-labeled anti-TF antibody, or captured using an anti-TF antibody and detected using fluorescent-labeled annexin V. EVs were visualized by LSCM.
TF+EVs were easily detected from high TF-expressing BxPc-3 cells using annexin V capture, whereas the addition of tyramide amplification was required to detect TF+EVs from low TF-expressing Panc-1 cells. Visualization of TF+EVs in plasma from LPS treated whole human blood and in plasma from pancreatic cancer patients required either capture with annexin V and detection with a fluorescent-labeled anti-TF antibody with tyramide signal amplification, or capture with an anti-TF antibody and detection with a fluorescent-labeled annexin V.
LSCM enables visualization of TF+EVs in the supernatant from cultured cells and in clinical samples.
在患有各种疾病(包括癌症和内毒素血症)的患者的血浆中,已经检测到组织因子阳性细胞外囊泡(TF+EVs)水平升高。可以通过抗原和活性测定法测量血浆样品中 TF+EVs 的水平。本研究的目的是通过激光扫描共聚焦显微镜(LSCM)可视化 TF+EVs。
从两种培养的人胰腺癌细胞系(Panc-1 和 BxPc-3)的上清液、未经处理或脂多糖(LPS)处理的全血以及胰腺癌患者的血浆中分离 EVs。使用内部测定法测定 EV-TF 活性。用 5(6)-羧基荧光素二乙酸酯 N-琥珀酰亚胺酯标记 EVs,该酯在 EV 内转化为不透的绿色荧光分子羧基荧光素。EV 可以使用膜联蛋白 V 捕获并用荧光标记的抗 TF 抗体检测,或者使用抗 TF 抗体捕获并用荧光标记的膜联蛋白 V 检测。通过 LSCM 可视化 EVs。
使用膜联蛋白 V 捕获,可以轻松从高 TF 表达的 BxPc-3 细胞中检测到 TF+EVs,而从低 TF 表达的 Panc-1 细胞中检测到 TF+EVs 则需要添加辣根过氧化物酶信号放大来检测。可视化 LPS 处理的全人血血浆和胰腺癌患者血浆中的 TF+EVs 需要使用膜联蛋白 V 捕获并用荧光标记的抗 TF 抗体进行检测,或使用抗 TF 抗体捕获并用荧光标记的膜联蛋白 V 进行检测。
LSCM 能够可视化培养细胞上清液和临床样本中的 TF+EVs。